Connection
Michael Allen to Antipsychotic Agents
This is a "connection" page, showing publications Michael Allen has written about Antipsychotic Agents.
|
|
Connection Strength |
|
|
|
|
|
3.878 |
|
|
|
-
Allen MH, Citrome L, Pikalov A, Hsu J, Loebel A. Efficacy of lurasidone in the treatment of agitation: A post hoc analysis of five short-term studies in acutely ill patients with schizophrenia. Gen Hosp Psychiatry. 2017 07; 47:75-82.
Score: 0.498
-
Nordstrom K, Allen MH. Alternative delivery systems for agents to treat acute agitation: progress to date. Drugs. 2013 Nov; 73(16):1783-92.
Score: 0.391
-
Allen MH, Feifel D, Lesem MD, Zimbroff DL, Ross R, Munzar P, Spyker DA, Cassella JV. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Oct; 72(10):1313-21.
Score: 0.338
-
Allen MH. Acute nonpsychotic mania: first episode. CNS Spectr. 2009 Nov; 14(11 Suppl 11):3-6; discussion 12-4.
Score: 0.296
-
Damsa C, Adam E, Lazignac C, Mihai A, DE Gregorio F, Lejeune J, Maris S, Clivaz E, Allen MH. A naturalistic study of consecutive agitated emergency department patients treated with intramuscular olanzapine prior to consent. Am J Psychiatry. 2008 Apr; 165(4):535-6.
Score: 0.265
-
Damsa C, Adam E, Lazignac C, De Gregorio F, Mihai A, Lejeune J, Sarasin F, Allen MH. Intramuscular olanzapine in patients with schizophrenia: an observational study in an emergency room. Bull Soc Sci Med Grand Duche Luxemb. 2008; (2):209-16.
Score: 0.261
-
Damsa C, Adam E, De Gregorio F, Cailhol L, Lejeune J, Lazignac C, Allen MH. Intramuscular olanzapine in patients with borderline personality disorder: an observational study in an emergency room. Gen Hosp Psychiatry. 2007 Jan-Feb; 29(1):51-3.
Score: 0.243
-
Damsa C, Ikelheimer D, Adam E, Maris S, Andreoli A, Lazignac C, Allen MH. Heisenberg in the ER: observation appears to reduce involuntary intramuscular injections in a psychiatric emergency service. Gen Hosp Psychiatry. 2006 Sep-Oct; 28(5):431-3.
Score: 0.238
-
Stuyt EB, Sajbel TA, Allen MH. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. Am J Addict. 2006 Mar-Apr; 15(2):166-73.
Score: 0.229
-
Allen MH, Currier GW. Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiatry. 2004 Jan-Feb; 26(1):42-9.
Score: 0.198
-
Alderfer BS, Allen MH. Treatment of agitation in bipolar disorder across the life cycle. J Clin Psychiatry. 2003; 64 Suppl 4:3-9.
Score: 0.184
-
Garriga M, Pacchiarotti I, Kasper S, Zeller SL, Allen MH, V?zquez G, Balda?ara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, M?ller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Hidalgo-Mazzei D, Passamar M, Messer T, Bernardo M, Vieta E. Assessment and management of agitation in psychiatry: Expert consensus. World J Biol Psychiatry. 2016; 17(2):86-128.
Score: 0.113
-
Kwentus J, Riesenberg RA, Marandi M, Manning RA, Allen MH, Fishman RS, Spyker DA, Kehne JH, Cassella JV. Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine. Bipolar Disord. 2012 Feb; 14(1):31-40.
Score: 0.086
-
Lesem MD, Tran-Johnson TK, Riesenberg RA, Feifel D, Allen MH, Fishman R, Spyker DA, Kehne JH, Cassella JV. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine. Br J Psychiatry. 2011 Jan; 198(1):51-8.
Score: 0.080
-
Nordstrom K, Allen MH. Managing the acutely agitated and psychotic patient. CNS Spectr. 2007 Oct; 12(10 Suppl 17):5-11.
Score: 0.064
-
Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA, Crandall DT. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. J Psychiatr Pract. 2007 May; 13(3):170-7.
Score: 0.062
-
Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R. Best clinical practice with ziprasidone IM: update after 2 years of experience. CNS Spectr. 2005 Sep; 10(9):1-15.
Score: 0.055
-
Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D. Novel therapies for treating acute agitation. J Emerg Med. 2004 Nov; 27(4 Suppl):S13-8.
Score: 0.052
-
Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D. Safety of medications used to treat acute agitation. J Emerg Med. 2004 Nov; 27(4 Suppl):S19-24.
Score: 0.052
-
Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D. Future directions in research. J Emerg Med. 2004 Nov; 27(4 Suppl):S27-9.
Score: 0.052
-
Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D. Intramuscular antipsychotics: clinical experience review. J Emerg Med. 2004 Nov; 27(4 Suppl):S3-4; quiz S8.
Score: 0.052
-
Currier GW, Allen MH, Bunney EB, Daniel DG, Francis A, Jagoda A, Zimbroff D. Standard therapies for acute agitation. J Emerg Med. 2004 Nov; 27(4 Suppl):S9-12; quiz S7.
Score: 0.052
-
Lukens TW, Wolf SJ, Edlow JA, Shahabuddin S, Allen MH, Currier GW, Jagoda AS. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med. 2006 Jan; 47(1):79-99.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|